[go: up one dir, main page]

ZA975828B - Stable medicament for oral administration and method for its production. - Google Patents

Stable medicament for oral administration and method for its production.

Info

Publication number
ZA975828B
ZA975828B ZA9705828A ZA975828A ZA975828B ZA 975828 B ZA975828 B ZA 975828B ZA 9705828 A ZA9705828 A ZA 9705828A ZA 975828 A ZA975828 A ZA 975828A ZA 975828 B ZA975828 B ZA 975828B
Authority
ZA
South Africa
Prior art keywords
oral administration
production
resistant
core
gastric juice
Prior art date
Application number
ZA9705828A
Other languages
English (en)
Inventor
Gerd-Ulfert Heese
Herbert Juenger
Arnim Laicher
Claudio Lorck
Thomas Profitlich
Gerd Weiss
Peter Wolfegg
Original Assignee
Klinge Co Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Co Chem Pharm Fab filed Critical Klinge Co Chem Pharm Fab
Publication of ZA975828B publication Critical patent/ZA975828B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9705828A 1996-06-28 1997-06-30 Stable medicament for oral administration and method for its production. ZA975828B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19626045A DE19626045C2 (de) 1996-06-28 1996-06-28 Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben

Publications (1)

Publication Number Publication Date
ZA975828B true ZA975828B (en) 1998-01-30

Family

ID=7798347

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9705828A ZA975828B (en) 1996-06-28 1997-06-30 Stable medicament for oral administration and method for its production.
ZA9705827A ZA975827B (en) 1996-06-28 1997-06-30 Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA9705827A ZA975827B (en) 1996-06-28 1997-06-30 Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.

Country Status (11)

Country Link
EP (1) EP0934058B1 (fr)
JP (1) JP4641075B2 (fr)
AT (1) ATE247457T1 (fr)
AU (2) AU3438897A (fr)
CA (1) CA2258918C (fr)
DE (2) DE19626045C2 (fr)
DK (1) DK0934058T3 (fr)
ES (1) ES2205243T3 (fr)
PT (1) PT934058E (fr)
WO (2) WO1998000114A2 (fr)
ZA (2) ZA975828B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DE69930648T2 (de) 1998-08-12 2006-12-21 Altana Pharma Ag Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US7316819B2 (en) * 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
KR100479637B1 (ko) * 2002-02-01 2005-03-31 한국화학연구원 란소프라졸을 함유하는 경구제제 및 그의 제조방법
ATE388695T1 (de) 2002-08-02 2008-03-15 Ratiopharm Gmbh Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
DE10235475B4 (de) * 2002-08-02 2006-04-27 Ratiopharm Gmbh Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
PT1648421T (pt) * 2003-07-24 2017-12-22 Glaxosmithkline Llc Películas de dissolução oral
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20070141137A1 (en) * 2004-03-04 2007-06-21 Naoki Nagahara Stable capsule preparation
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MX2007008141A (es) * 2005-01-03 2007-12-10 Lupin Ltd Composicion farmaceutica de sustancias labiles en medio acido.
DE102005032806A1 (de) * 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
CA2687130C (fr) * 2007-05-07 2017-10-03 Evonik Roehm Gmbh Formes posologiques solides comprenant un revetement gastroresistant et presentant une liberation acceleree du medicament
DE102008056312A1 (de) 2008-11-07 2010-05-12 Biogenerics Pharma Gmbh Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz
DE102010052847A1 (de) * 2010-11-29 2012-05-31 Temmler Werke Gmbh Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung
US8951996B2 (en) * 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
JP5934835B2 (ja) * 2013-03-08 2016-06-15 富士フイルム株式会社 腸溶性細粒及び医薬組成物
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
AU2019250894B2 (en) * 2018-04-12 2024-09-12 Bpsi Holdings Llc Acidifying coatings and disintegration-resistant substrates coated therewith
KR20220113941A (ko) * 2019-12-11 2022-08-17 에보닉 오퍼레이션스 게엠베하 질환을 치료 또는 예방하는데 사용하기 위한 투여 형태

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS584730A (ja) * 1981-06-29 1983-01-11 Shin Etsu Chem Co Ltd 腸溶性コ−テイング組成物およびその製造方法
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
JPH0733659A (ja) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
WO1994002140A1 (fr) * 1992-07-17 1994-02-03 Astra Aktiebolag Composition pharmaceutique contenant un agent antiulcereux
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation

Also Published As

Publication number Publication date
JP4641075B2 (ja) 2011-03-02
CA2258918A1 (fr) 1998-01-08
AU3438897A (en) 1998-01-21
DE19626045A1 (de) 1998-01-08
PT934058E (pt) 2004-01-30
JP2000514051A (ja) 2000-10-24
CA2258918C (fr) 2005-11-22
EP0934058A2 (fr) 1999-08-11
AU3345197A (en) 1998-01-21
DK0934058T3 (da) 2003-12-01
DE59710629D1 (de) 2003-09-25
ZA975827B (en) 1998-01-30
WO1998000114A2 (fr) 1998-01-08
ATE247457T1 (de) 2003-09-15
WO1998000115A3 (fr) 1998-02-26
DE19626045C2 (de) 1998-12-03
ES2205243T3 (es) 2004-05-01
EP0934058B1 (fr) 2003-08-20
WO1998000115A2 (fr) 1998-01-08
WO1998000114A3 (fr) 1998-02-26

Similar Documents

Publication Publication Date Title
ZA975828B (en) Stable medicament for oral administration and method for its production.
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
AU531280B2 (en) Cardiac glycoside composition
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
MY102675A (en) Pharmaceutical formulations of acid labile substances for oral use.
CA2232356A1 (fr) Procede de preparation de formes galeniques solides multicouches pour administration orale ou rectale
EP0729748A4 (fr) Procede pour produire une composition de medicament stable, et preparation pharmaceutique
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
HUT59306A (en) Process for producing pharmaceutical compositions comprising l-carnitine
MX9500885A (es) Preparacion farmaceutica para administracion oral.
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
CA2093666A1 (fr) Preparation pharmaceutique sans solvant pour administration par voie orale permettant une liberation prolongee de l'ingredient actif et methode de fabrication de ladite preparation
WO1999007401A3 (fr) Utilisation de preparations d'erythropoietine et de fer pour la production de preparations pharmaceutiques mixtes destinees au traitement de maladies rhumatismales
GR1002847B (el) Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
CA2032475A1 (fr) Preparations pharmaceutiques pour administration par voie orale permettant la liberation du medicament dans des endroits cibles de l'intestin
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
EP0161816A3 (fr) Urogastrone
EP0649660A3 (fr) Compositions pharmaceutiques pour l'administration parentérale, entérale et dermale d'agents actifs pratiquement insolubles, et procédé pour leur fabrication.
HRP960081B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them
WO2002041897A3 (fr) Compositions pharmaceutiques a action antidiabetique constitues de l'association d'un biguanide et d'un sulfonamide
WO2002045618A3 (fr) Capsule a avaler pour l'administration de comprimes aux animaux
NO326141B1 (no) Fremgangsmate for behandling av isolert systolisk hypertensjon